Soon after the introduction of atypical antipsychotics, which antagonize serotonin receptors and dopamine D2 receptors (D2R), numerous case reports appeared showing that the use of these drugs were associated with increased obesity and the development of type 2 diabetes mellitus (T2DM) (5). Here, DRD2 is linked to obesity due to melanocortin 4 receptor deficiency.